schizophrenia
Conditions
Interventions
Active tDCS stimulation + music therapy group:Conduct active tDCS stimulation with a current intensity of 2mA, once a day for a total of 20 sessions. Engage in music therapy with a fixed playlist, onc
Active tDCS stimulation group:Conduct active tDCS stimulation with a current intensity of 2mA, once a day for a total of 20 sessions
Sham tDCS stimulation + music therapy group:Perform sham tDCS stimulation with a current intensity of 2mA, once a day for a total of 20 sessions.Engage in music therapy with a fixed playlist, once a d
music therapy group:Engage in music therapy with a fixed playlist, once a day for a total of 20 sessions.
control group:Maintain daily medication without intervention of tDCS and music therapy.
Sponsors
The Second Affiliated Hospital of Xinxiang Medical University
Eligibility
Sex/Gender
All
Age
13 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1.Meets the clinical diagnostic criteria for schizophrenia according to DSM-5 for the current episode 2.Currently undergoing treatment with atypical antipsychotic medications, with equivalent doses of antipsychotic drugs calculated using the defined daily dose method 3.Disease course of more than 1 year 4.Han ethnicity 5.Ages between 13-55 years 6.A gender ratio of 1:1 7.Obtained written informed consent from the patient 8.Normal hearing 9.Junior high school education or above
Exclusion criteria
Exclusion criteria: 1.Presence of brain organic lesions, intellectual disability, or other physical illnesses 2.Intracranial hypertension 3.Frequent and persistent migraines 4.History of epilepsy or family history of epilepsy 5.Presence of metal implants in the body 6.Severe drug and alcohol dependence 7.Pregnant or lactating women 8.Current significant laboratory abnormalities 9.Currently undergoing MECT treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MATRICS Consensus Cognitive Battery;Repeatable Battery for the Assessment of Neuropsychological Status;Brief Psychiatric Rating Scale;Positive and Negative Syndrome Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical Global Impressions;Functional Near-Infrared Spectroscopy;General Information Questionnaire; | — |
Countries
China
Contacts
Public ContactYange Wei
The Second Affiliated Hospital of Xinxiang Medical University.
Outcome results
None listed